NOTCH1 and squamous cell carcinoma: Since this seminal discovery in 2004 [77], mutations, deletions and amplifications (indels) of NOTCH receptors, mainly of NOTCH1, have been identified in most or all epithelial cancers, including breast adenocarcinoma and various squamous cell carcinomas [30,78].